ES539799A0 - Un procedimiento para la preparacion de hexahidro-arilquinolizinas sustituidas. - Google Patents
Un procedimiento para la preparacion de hexahidro-arilquinolizinas sustituidas.Info
- Publication number
- ES539799A0 ES539799A0 ES539799A ES539799A ES539799A0 ES 539799 A0 ES539799 A0 ES 539799A0 ES 539799 A ES539799 A ES 539799A ES 539799 A ES539799 A ES 539799A ES 539799 A0 ES539799 A0 ES 539799A0
- Authority
- ES
- Spain
- Prior art keywords
- substituted
- arilquinolizinas
- hexahidro
- procedure
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57623384A | 1984-02-02 | 1984-02-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES539799A0 true ES539799A0 (es) | 1986-07-16 |
| ES8609323A1 ES8609323A1 (es) | 1986-07-16 |
Family
ID=24303506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES539799A Expired ES8609323A1 (es) | 1984-02-02 | 1985-01-24 | Un procedimiento para la preparacion de hexahidro-arilquinolizinas sustituidas. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0154142B1 (es) |
| JP (1) | JPS60188385A (es) |
| KR (1) | KR900003651B1 (es) |
| AT (1) | ATE44529T1 (es) |
| AU (1) | AU576550B2 (es) |
| CA (1) | CA1240677A (es) |
| DE (1) | DE3571438D1 (es) |
| DK (1) | DK45385A (es) |
| ES (1) | ES8609323A1 (es) |
| GR (1) | GR850211B (es) |
| IE (1) | IE850253L (es) |
| IL (1) | IL74147A (es) |
| NZ (1) | NZ210982A (es) |
| PT (1) | PT79871B (es) |
| ZA (1) | ZA85789B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4690928A (en) * | 1984-02-02 | 1987-09-01 | Merck & Co., Inc. | Substituted hexahydro arylquinolizines as α2 blockers |
| GB8420602D0 (en) * | 1984-08-14 | 1984-09-19 | Wyeth John & Brother Ltd | Thienoquinolizines |
| DK127086A (da) * | 1985-03-25 | 1986-09-26 | Schering Corp | Substituerede 1,8-naphthyridoner, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner, der indeholder disse forbindelser |
| AU582663B2 (en) * | 1985-08-10 | 1989-04-06 | John Wyeth & Brother Limited | Sulphonamides |
| US4686226A (en) * | 1985-09-03 | 1987-08-11 | Merck & Co., Inc. | Substituted benzo[b]furo- and benzo[b]thieno quinolizines |
| US4835276A (en) * | 1986-07-03 | 1989-05-30 | Merck & Co., Inc. | Preparation of n-formamidoyl[(s)-1-t-butoxy-3-methyl-2-amino)]1,2,3,4 tetrahydrobenzo [b]furo [2,3-c]pyridine and derivatives |
| US4814452A (en) * | 1986-07-03 | 1989-03-21 | Merck & Co., Inc. | Enantioselective synthesis of 1,3,4,6,7,12b(S)-hexahydro-2H-benzo[b]furo[2,3-a]quinolizin-2-one |
| US4831035A (en) * | 1986-08-28 | 1989-05-16 | Merck & Co., Inc. | Substituted hexahydroarylquinolizines |
| NZ221485A (en) * | 1986-08-28 | 1991-04-26 | Merck & Co Inc | Hexahydroarylquinolizine derivatives and pharmaceutical compositions |
| US4956365A (en) * | 1987-04-13 | 1990-09-11 | Syntex (U.S.A.) Inc. | Decahydro-8H-isoquino(2,1-g)(1,6)naphthyridine derivatives and related compounds |
| CA1321751C (en) * | 1989-02-21 | 1993-08-31 | Eugene C. Crichlow | Mechanism mediating ruminal stasis in ruminal lactic acidosis |
| WO2011067145A1 (en) | 2009-12-04 | 2011-06-09 | Nerviano Medical Sciences S.R.L. | Tricyclopyrazole derivatives |
| GB201509006D0 (en) | 2015-05-26 | 2015-07-08 | Redx Pharma Plc | Antibacterial compounds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1470065C3 (de) * | 1961-06-19 | 1980-07-17 | Merck Patent Gmbh, 6100 Darmstadt | Verfahren zur Herstellung von Chinolizinderivaten |
| GB1435573A (en) * | 1973-05-25 | 1976-05-12 | Wyeth John & Brother Ltd | Indoloquinolizines |
| US4181657A (en) * | 1978-07-14 | 1980-01-01 | Miles Laboratories, Inc. | 2-Aminooctahydroindolo[2,3-a]quinolizines useful in treating cardiovascular disorders |
| GB2106909B (en) * | 1981-10-07 | 1984-09-19 | Wyeth John & Brother Ltd | Benzoquinolizines |
-
1985
- 1985-01-24 IL IL74147A patent/IL74147A/xx unknown
- 1985-01-24 PT PT79871A patent/PT79871B/pt unknown
- 1985-01-24 GR GR850211A patent/GR850211B/el unknown
- 1985-01-24 ES ES539799A patent/ES8609323A1/es not_active Expired
- 1985-01-25 DE DE8585100732T patent/DE3571438D1/de not_active Expired
- 1985-01-25 AT AT85100732T patent/ATE44529T1/de not_active IP Right Cessation
- 1985-01-25 EP EP85100732A patent/EP0154142B1/en not_active Expired
- 1985-01-29 NZ NZ210982A patent/NZ210982A/en unknown
- 1985-01-31 CA CA000473300A patent/CA1240677A/en not_active Expired
- 1985-01-31 AU AU38220/85A patent/AU576550B2/en not_active Ceased
- 1985-02-01 DK DK45385A patent/DK45385A/da not_active Application Discontinuation
- 1985-02-01 KR KR1019850000635A patent/KR900003651B1/ko active IP Right Grant
- 1985-02-01 JP JP60016693A patent/JPS60188385A/ja active Pending
- 1985-02-01 ZA ZA85789A patent/ZA85789B/xx unknown
- 1985-02-01 IE IE850253A patent/IE850253L/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE850253L (en) | 1985-08-02 |
| IL74147A0 (en) | 1985-04-30 |
| KR900003651B1 (ko) | 1990-05-28 |
| AU3822085A (en) | 1985-08-08 |
| EP0154142A1 (en) | 1985-09-11 |
| NZ210982A (en) | 1988-04-29 |
| AU576550B2 (en) | 1988-09-01 |
| DK45385D0 (da) | 1985-02-01 |
| ES8609323A1 (es) | 1986-07-16 |
| CA1240677A (en) | 1988-08-16 |
| IL74147A (en) | 1988-08-31 |
| DK45385A (da) | 1985-09-18 |
| PT79871B (en) | 1986-12-15 |
| DE3571438D1 (en) | 1989-08-17 |
| PT79871A (en) | 1985-02-01 |
| JPS60188385A (ja) | 1985-09-25 |
| ZA85789B (en) | 1986-09-24 |
| EP0154142B1 (en) | 1989-07-12 |
| ATE44529T1 (de) | 1989-07-15 |
| KR850005843A (ko) | 1985-09-26 |
| GR850211B (es) | 1985-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2016807B3 (es) | Procedimiento para la preparacion de 2-oxo-1,3-dioxolanos. | |
| ES539799A0 (es) | Un procedimiento para la preparacion de hexahidro-arilquinolizinas sustituidas. | |
| MX11117A (es) | Procedimiento para la preparacion de nuevos antagonistas opioides de la piperidina. | |
| ES556864A0 (es) | Procedimiento para la obtencion de benzopiranos sustituidos. | |
| ES519854A0 (es) | Un procedimiento para la preparacion de 1-(3-halo-2-piridinil) piperazinas. | |
| ES554659A0 (es) | Un procedimiento para la preparacion de derivados de piperazimilo 1,4-di sustituidos. | |
| NO901631L (no) | Fremgangsmaate for fremstilling av 2-substituerte n,n'-ditrimetoksybenzoyl-piperaziner. | |
| IT1230068B (it) | Procedimento per la preparazione di n sulfoniluree. | |
| ES550874A0 (es) | Un procedimiento para la preparacion de 3,4-dihidroxifemetilamino derivados 2-ustituidos. | |
| ES556208A0 (es) | Un procedimiento para la preparacion de benzimidazoles. | |
| IT8619206A0 (it) | Procedimento per la preparazione di 4,4-dialchil-2-azetidinoni. | |
| IT8323383A0 (it) | Procedimento per la realizzazione di pannelli per l'ottenimento di mobili e simili, nonche' macchina automatica per la sua attuazione. | |
| ES8707729A1 (es) | Un procedimiento para la preparacion de hexahidroarilquinolizinas sustituidas. | |
| IT8719009A0 (it) | Composti antagonisti di recettori -h2 e procedimento per la loro preparazione. | |
| NO891025L (no) | Fremgangsmaate for fremstilling av nye, terapeutisk aktivesialosylglycerider. | |
| IT8520089A0 (it) | Procedimento per la preparazionedi w-lattami, in particolare caprolattame. | |
| ES515452A0 (es) | "procedimiento para la preparacion de nuevos derivados de anilino-1,2,3-triazol". | |
| DE69004455D1 (de) | Alpha-adrenergene Rezeptor-Antagonisten. | |
| IT8822438A0 (it) | Procedimento per la preparazione di ceftriaxone e i suoi sali farmaceuticamente accettabili. | |
| IT8619931A0 (it) | Procedimento per la preparazione della 1-(n-metilamidino)-3-(2,6-dimetilfe nil) urea e dei suoi sali farmaceuticamente accettabili. | |
| IT8522409A0 (it) | Procedimento per la produzione di2,3-diidro-2,2-dimetil-7-benzofuranolo. | |
| IT8822273A0 (it) | Procedimento per la preparazione di 1,2-difluoro-1,1,2,2tetacloroetano sostanzialmente privo dell'isomero 1,1-difluoro 1,2,2,2-tetracloroetano. | |
| IT8420686A0 (it) | Procedimenti per la preparazione di derivati delbis-idrossietilmercapto-1,10-decano. | |
| ES1007762Y (es) | Soportes perfeccionados para la union de estructuras de invernadero. | |
| NO883313D0 (no) | Fremgangsmaate til fremstilling av chips av potetdfremgamgsmaate til fremstilling av chips af potetdeig eig. |